Core--Chemical
核心--化学
基本信息
- 批准号:6564810
- 负责人:
- 金额:$ 39.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-01 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Chemical Core has the long term objective and specific aim of providing a unique resource of fluorescent and photosensitive "caged" nucleotides for exploring mechanisms of smooth muscle physiology and cell biology. The specific health benefits of the research relevant to this program project are set out in the Introduction (Significance" and in the individual projects. The Core will achieve its goals principally through (1) synthesis of coumarin-labeled nucleotides that will enable crossbridge states to be identified and their rates of formation and decay measured; (2) the synthesis of novel caged nucleotides and regulators of smooth muscle including caged phosphorylated myosin regulatory light chains. The methods for achieving these goals will be through chemical protocols established in the laboratories of the principal investigators. This synthetic chemistry program will be supported by rigorous characterization of the probes (by monitoring their activity and function when interacting with isolated muscle proteins) and the caged compounds (by monitoring their photochemical properties and (desirable) biological inertness). Further goals will be achieved by development of real-time probes of Pi and ADP that will be applied (Project 1) to record smooth muscle ATPase activity in various physiological states and pseudo- ATPase (myosin light chain kinase/smooth muscle phosphatase) activity. Finally, the reagents will, insofar as is practical, be tested in a physiological environment by probing their behavior in skinned skeletal muscle fibers. The expertise and collaboration of chemists, enzymologists and physiologists in the Division of Physical Biochemistry at NIMR make this a unique chemical core facility.
化学核心的长期目标和具体目标是提供独特的荧光和光敏“笼式”核苷酸资源,用于探索平滑肌生理学和细胞生物学的机制。与该方案项目相关的研究的具体健康益处列于导言(意义“和个别项目中)。Core将主要通过(1)合成香豆素标记的核苷酸,从而能够识别交叉桥状态并测量其形成和衰退的速度;(2)合成新型的笼状核苷酸和包括笼状磷酸化肌球蛋白调节轻链在内的平滑肌调节器,从而实现其目标。实现这些目标的方法将是通过在主要调查人员的实验室中制定的化学方案。这一合成化学计划将得到对探针(通过监测它们与分离的肌肉蛋白相互作用时的活性和功能)和笼状化合物(通过监测它们的光化学性质和(理想的)生物惰性)的严格表征的支持。进一步的目标将通过开发PI和ADP的实时探针来实现,这些探针将被应用(项目1)来记录不同生理状态下的平滑肌ATPase活性和伪ATPase(肌球蛋白轻链激酶/平滑肌磷酸酶)活性。最后,只要可行,这些试剂将在生理环境中通过探测它们在去皮骨骼肌纤维中的行为来进行测试。NIMR物理生物化学部的化学家、酶学家和生理学家的专业知识和合作使其成为一个独特的化学核心设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID TRENTHAM其他文献
DAVID TRENTHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID TRENTHAM', 18)}}的其他基金
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
活动性类风湿关节炎患者口服口服药与安慰剂的比较
- 批准号:
6118929 - 财政年份:1998
- 资助金额:
$ 39.96万 - 项目类别:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
口服 II 型胶原蛋白治疗幼年类风湿关节炎的开放标签研究
- 批准号:
6118900 - 财政年份:1998
- 资助金额:
$ 39.96万 - 项目类别:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
口服 II 型胶原蛋白治疗幼年类风湿关节炎的开放标签研究
- 批准号:
6250109 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
THERAFECTIN COMPARED TO PLACEBO IN PATIENTS WITH RHEUMATOID ARTHRITIS
Therafectin 与安慰剂治疗类风湿性关节炎患者的比较
- 批准号:
6250157 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
OPEN LABEL STUDY OF ORAL TYPE II COLLAGEN IN JUVENILE RHEUMATOID ARTHRITIS
口服 II 型胶原蛋白治疗幼年类风湿关节炎的开放标签研究
- 批准号:
6279920 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
活动性类风湿关节炎患者口服口服药与安慰剂的比较
- 批准号:
6279949 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
THERAFECTIN COMPARED TO PLACEBO IN PATIENTS WITH RHEUMATOID ARTHRITIS
Therafectin 与安慰剂治疗类风湿性关节炎患者的比较
- 批准号:
6279948 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
COMPARISON OF ORAL COLLORAL WITH PLACEBO IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
活动性类风湿关节炎患者口服口服药与安慰剂的比较
- 批准号:
6250158 - 财政年份:1997
- 资助金额:
$ 39.96万 - 项目类别:
MIRA - MINOCYCLINE IN RHEUMATOID ARTHRITIS
MIRA - 米诺环素治疗类风湿性关节炎
- 批准号:
2298280 - 财政年份:1991
- 资助金额:
$ 39.96万 - 项目类别:
相似海外基金
PFI-TT: Chemical Synthesis of a Natural Product Family of Compounds for Tick-Targeted Prevention and Control
PFI-TT:用于蜱目标预防和控制的天然产物化合物家族的化学合成
- 批准号:
2345757 - 财政年份:2024
- 资助金额:
$ 39.96万 - 项目类别:
Standard Grant
Reactions without walls: Droplet Reaction Module for rapid chemical synthesis (DReaM)
无壁反应:用于快速化学合成的液滴反应模块 (DReaM)
- 批准号:
2896295 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Studentship
Chemical synthesis and exploration of concerted optical properties of anisotropic three-dimensional quantum dot superlattices
各向异性三维量子点超晶格的化学合成及协同光学性质探索
- 批准号:
23H01802 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
domino4chem: Semi-biological Domino Catalysis for Solar Chemical Synthesis
domino4chem:用于太阳能化学合成的半生物多米诺催化
- 批准号:
EP/X030563/1 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Research Grant
Chemical Synthesis and Biological Application of Carbohydrates and Glycoconjugates
碳水化合物和糖复合物的化学合成和生物应用
- 批准号:
10552167 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment
通过化学合成和目标分配对 Galbulimima 树皮药理学进行解卷积
- 批准号:
10682293 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Microfluidic Systems to Enable Enzyme Engineering for Chemical Synthesis
微流体系统使酶工程能够用于化学合成
- 批准号:
10715356 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
CAREER: Merging Graph Theory and Automation for Chemical Synthesis
职业:将图论与化学合成自动化相结合
- 批准号:
2236215 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Continuing Grant
ChemDecEpi: A Chemical Synthesis Approach towards Decoding the Epitranscriptome
ChemDecEpi:解码表观转录组的化学合成方法
- 批准号:
EP/X032043/1 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
Research Grant
Next Generation Photocatalysis for Chemical Synthesis and Manufacture
用于化学合成和制造的下一代光催化
- 批准号:
FT220100345 - 财政年份:2023
- 资助金额:
$ 39.96万 - 项目类别:
ARC Future Fellowships














{{item.name}}会员




